Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth
Completed
- Conditions
- Effectiveness of Biodentine® in Pulpotomies Primary Teeth
- Registration Number
- NCT01655342
- Lead Sponsor
- Hadassah Medical Organization
- Brief Summary
Clinical and radiographic assessment of Biodentine® as a pulp dressing material for pulpotomy treatment in human primary molars.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
- one or more primary teeth which requires pulpotomy.
Exclusion Criteria
- not healthy patients,
- patients with teeth which requires pulpectomy.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success of the primary molar pulpotomy One year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Biodentine®'s efficacy in primary molar pulpotomies compared to traditional materials?
How does Biodentine® compare to MTA or calcium hydroxide in clinical outcomes for primary tooth pulpotomies?
Are there specific biomarkers associated with successful pulp healing after Biodentine® application in primary molars?
What adverse events are reported with Biodentine® use in pediatric pulpotomies and how are they managed?
What alternative pulp capping agents or combination therapies are being evaluated alongside Biodentine® in pediatric dentistry?
Trial Locations
- Locations (1)
Hadassah Medical Organization
🇮🇱Jerusalem, Israel
Hadassah Medical Organization🇮🇱Jerusalem, Israel